Piperlongumine inhibits GSTP1 (glutathione S-transferase P1), reducing antioxidant capacity specifically in senescent cells. Senescent cells have elevated baseline ROS from persistent DNA damage signaling; further reducing antioxidant capacity tips them into ROS-triggered apoptosis. Normal cells with intact GSTP1 activity are not significantly affected.

Is black pepper the same as long pepper for piperlongumine?

No. Black pepper (Piper nigrum) contains piperine; long pepper (Piper longum) contains piperlongumine. They are different species with different bioactive alkaloids. Commercial black pepper supplements do not provide meaningful piperlongumine.

When might piperlongumine be available clinically?

No clinical trials for piperlongumine in aging are currently registered. The compound needs pharmacokinetic characterization and dose-finding studies before human senolytic use would be appropriate.